# Current Knowledge on UTUC Epidemiology in Poland Compared to Europe

## TL;DR

This study compares the epidemiology of upper tract urothelial carcinoma in Poland to other European countries, finding a unique pattern with a smaller gap between incidence and mortality.

## Contribution

The study provides the first detailed comparison of UTUC trends in Poland versus Europe, highlighting distinct sex-specific patterns.

## Key findings

- UTUC incidence and mortality rates in Poland increased from 2000 to 2017 but later declined in women.
- Poland shows a smaller gap between UTUC incidence and mortality compared to most European countries.
- Five-year relative survival for UTUC in Poland reached 55–62%, with improvements over time.

## Abstract

Upper tract urothelial carcinoma (UTUC) is a rare cancer with limited epidemiological data from Central and Eastern Europe. Using nationwide Polish and European data from two decades, we analyzed UTUC incidence, mortality, and survival patterns. Poland shows a distinct sex-specific epidemiological pattern, with a smaller gap between incidence and mortality compared to most European countries. These findings highlight the need for better national registries and centralized care to improve patient outcomes.

Background: Upper tract urothelial carcinoma (UTUC) is a rare malignancy with limited epidemiological data from Central and Eastern Europe. This study aimed to evaluate long-term trends in UTUC incidence, mortality, and survival in Poland and to compare them with other European countries. Methods: Incidence and mortality data were acquired from Polish National Cancer Registry, Statistics Poland and European Cancer Information System. Age-standardized incidence and mortality rates were calculated using the European Standard Population (ESP 2013). Temporal trends were assessed using Joinpoint regression, and five-year relative survival was estimated with the Pohar–Perme method. Results: Our study demonstrated significantly higher incidence and mortality rates of UTUC across Europe compared to the initial observation period, consistent with the data from Poland. UTUC incidence increased in Poland between 2000 and 2017 (average annual percent change [AAPC] 5.6% in women and 9.9% in men), followed by a decline among women after 2017 (AAPC −1.3%). Mortality initially rose in both sexes but decreased in recent years, particularly in men (AAPC −5.47%). Renal pelvis cancer showed higher incidence and mortality than ureteral cancer. Compared with other European countries, Poland exhibited a smaller gap between incidence and mortality. Five-year relative survival improved over time, reaching 55–56% for renal pelvis cancer and up to 62% for ureteral cancer. Conclusions: UTUC incidence and mortality are rising in Europe, but Poland displays a distinctive epidemiological pattern. Strengthening national cancer registries and implementing centralized care protocols may improve disease management and reduce mortality.